Denis Chem Lab Ltd

Denis Chem Lab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Denis Chem Lab Ltd

₹ 90.0 -2.79%
16 Oct - close price
denischemlab.com BSE: 537536
About

Incorporated in 1982, Denis Chem Lab Ltd does manufacturing of Pharmaceuticals Transfusion Solution in Bottles[1]

Key Points

Business Overview:[1]
DCLL manufactures and markets sterile Intravenous injectibles in Glass and Plastic Bottles for human and veterinary consumption. It also manufactures products on contract basis for multinational pharmaceutical companies who market them under their own brands. Company has a fully equipped in-house Quality Control Laboratory having different interdepartments for Chemical Testing, Physico-Chemical Testing, Microbiological Testing, Pyrogens Testing, Sterility Testing and Toxicity Testing. All raw materials, packaging materials, in process testing and finished stocks are tested in-house.

Website BSE
  • Market Cap ₹ 125 Cr.
  • Current Price ₹ 90.0
  • High / Low ₹ 193 / 88.0
  • Stock P/E 14.7
  • Book Value ₹ 61.3
  • Dividend Yield 1.67 %
  • ROCE 13.9 %
  • ROE 9.77 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 30.7%

Cons

  • The company has delivered a poor sales growth of 5.03% over past five years.
  • Promoter holding is low: 39.0%
  • Company has a low return on equity of 11.9% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
39.29 44.51 37.33 39.73 42.48 45.43 40.06 39.85 41.26 47.82 42.84 41.38 43.28
34.99 38.74 33.38 34.99 37.45 40.29 34.07 34.77 36.91 41.94 39.01 39.32 38.46
Operating Profit 4.30 5.77 3.95 4.74 5.03 5.14 5.99 5.08 4.35 5.88 3.83 2.06 4.82
OPM % 10.94% 12.96% 10.58% 11.93% 11.84% 11.31% 14.95% 12.75% 10.54% 12.30% 8.94% 4.98% 11.14%
0.08 0.11 0.07 0.34 0.01 0.52 0.26 0.59 0.32 0.58 0.30 1.17 0.30
Interest 0.17 0.08 0.12 0.26 0.09 0.09 0.13 0.23 0.12 0.09 0.07 0.23 0.19
Depreciation 1.36 1.37 1.37 3.72 1.59 1.76 1.84 1.75 1.63 1.66 1.84 1.73 1.61
Profit before tax 2.85 4.43 2.53 1.10 3.36 3.81 4.28 3.69 2.92 4.71 2.22 1.27 3.32
Tax % 24.91% 29.80% 28.06% 29.09% 20.24% 33.07% 25.23% 26.02% 28.77% 25.05% 20.72% 44.09% 25.30%
2.15 3.11 1.83 0.78 2.68 2.54 3.20 2.73 2.08 3.53 1.76 0.71 2.48
EPS in Rs 1.55 2.24 1.32 0.56 1.93 1.83 2.31 1.97 1.50 2.54 1.27 0.51 1.79
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
67 75 98 112 107 123 135 109 136 161 167 173 175
60 66 89 98 95 110 120 99 122 142 146 157 159
Operating Profit 6 9 8 14 12 14 15 10 14 19 21 16 17
OPM % 9% 12% 9% 12% 11% 11% 11% 9% 11% 12% 13% 9% 9%
0 0 0 1 1 2 0 0 1 1 1 2 2
Interest 3 5 7 6 5 3 3 2 1 1 1 1 1
Depreciation 1 4 6 7 6 6 7 6 6 8 7 7 7
Profit before tax 2 0 -3 2 2 6 6 3 9 11 15 11 12
Tax % 41% 78% 30% 37% -5% -7% 26% 27% 30% 28% 26% 27%
1 0 -4 1 2 6 4 2 6 8 11 8 8
EPS in Rs 1.17 0.07 -4.16 0.89 1.54 4.58 3.03 1.63 4.51 5.66 8.04 5.82 6.11
Dividend Payout % 0% 0% 0% 0% 0% 22% 0% 46% 33% 35% 31% 26%
Compounded Sales Growth
10 Years: 9%
5 Years: 5%
3 Years: 8%
TTM: 5%
Compounded Profit Growth
10 Years: 59%
5 Years: 14%
3 Years: 9%
TTM: -20%
Stock Price CAGR
10 Years: 5%
5 Years: 12%
3 Years: 6%
1 Year: -47%
Return on Equity
10 Years: 8%
5 Years: 10%
3 Years: 12%
Last Year: 10%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 3 9 9 12 14 14 14 14 14 14 14 14
Reserves 6 8 7 18 36 43 45 48 53 58 66 71
31 48 44 37 25 23 14 9 3 2 1 1
12 17 24 27 26 26 25 22 27 25 28 26
Total Liabilities 52 81 85 94 101 106 97 92 96 99 109 112
9 42 40 44 40 50 46 41 42 35 38 39
CWIP 9 0 10 1 5 0 0 0 0 2 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
34 39 35 49 56 55 52 51 55 62 72 73
Total Assets 52 81 85 94 101 106 97 92 96 99 109 112

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-2 14 21 7 11 8 13 8 17 16 18 12
-9 -28 -13 -1 -16 -2 -2 -1 -10 -11 -15 -8
12 13 -7 -0 1 -5 -14 -6 -7 -4 -4 -4
Net Cash Flow 0 -1 1 5 -4 1 -3 1 -0 1 -1 -0

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 91 123 85 104 105 106 94 110 85 71 69 65
Inventory Days 37 40 39 35 52 50 51 60 50 39 43 37
Days Payable 53 81 119 136 150 102 108 103 99 79 90 81
Cash Conversion Cycle 75 81 4 3 8 55 37 67 36 31 22 21
Working Capital Days 32 -19 -57 -13 4 17 32 63 51 41 37 38
ROCE % 16% 11% 5% 12% 9% 11% 11% 6% 14% 16% 20% 14%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
38.98% 38.98% 38.98% 38.98% 38.98% 38.98% 38.98% 38.98% 38.98% 38.98% 38.98% 38.98%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.01%
61.02% 61.03% 61.03% 61.02% 61.02% 61.01% 61.02% 61.01% 61.01% 61.02% 61.01% 61.00%
No. of Shareholders 3,4323,4933,7234,6354,7944,8346,0216,8577,3857,2187,2277,304

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings